APA (7th ed.) Citation

R, K., E, B., H, B., A, C., T, D., B, K., . . . P, S. (2022). Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a Treatment for Preferential Wound Healing Outcome. Stem cells translational medicine, 11(8), 861. https://doi.org/10.1093/stcltm/szac037

Chicago Style (17th ed.) Citation

R, Knight, et al. "Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a Treatment for Preferential Wound Healing Outcome." Stem Cells Translational Medicine 11, no. 8 (2022): 861. https://doi.org/10.1093/stcltm/szac037.

MLA (9th ed.) Citation

R, Knight, et al. "Oral Progenitor Cell Line-Derived Small Extracellular Vesicles as a Treatment for Preferential Wound Healing Outcome." Stem Cells Translational Medicine, vol. 11, no. 8, 2022, p. 861, https://doi.org/10.1093/stcltm/szac037.